What Antleron does

Antleron NV is a Belgian private biotechnology company headquartered in Leuven that develops technology and services for the manufacturing of advanced therapy medicinal products (ATMPs), including cell therapies, gene therapies, and regenerative medicine. Founded in 2014 and operating from the BioIncubator in Leuven, the company positions itself as an advanced therapy partner to pharma, biotech, and academic customers, with a headcount in the 11–50 range.

The company's core technology is a hybrid bioprocess platform that pairs the proprietary CellGuide fixed-bed bioreactor — a scalable, closed, and automated upstream system for adherent cell culture including HEK cells used in rAAV production — with NEXUS, a digital twin counterpart that runs computational fluid dynamics simulations (via Ansys Fluent) combined with hybrid mechanistic and machine-learning models for in silico bioprocess simulation and optimization. This stack is complemented by soft sensing capabilities (non-invasive monitoring of pH, dissolved oxygen, metabolites, impedance, and Raman), additive-manufactured custom bioreactor components, the BioScout biomaterial screening platform, and the Cell by Design cloud software co-developed with QbD for risk-based process assessment. Service offerings span mesenchymal stem cell bioprocess engineering, rAAV vector manufacturing, and extracellular vesicle production.

Antleron monetizes through two streams: custom bioprocess development and process optimization services sold to ATMP developers on a quote-based consultative basis, and licensing of the CellGuide/NEXUS technology platform. Distribution is exclusively direct enterprise sales — a B2B motion targeting pharma and biotech companies developing advanced therapies, biomaterial and medical device manufacturers, and academic research institutions. Marketing relies on thought-leadership content (LinkedIn, technical blogs, white papers), industry conference presence (ESACT, TERMIS, Ansys Simulation World), and an active ecosystem of co-development partners including Ansys, Novasign, QbD, Rousselot, Ghent University, and EU-funded doctoral networks such as LifeLUNG and GET-IN.

Name

Antleron

Legal name

Antleron NV

Website

https://antleron.com

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

11–50 employees

Short description

Antleron is a Belgian biotech that develops the CellGuide fixed-bed bioreactor and NEXUS digital twin platform, plus custom bioprocess services, to help pharma, biotech, and academic customers scale up cell and gene therapy manufacturing.

Ownership category

akta.pro rank

Product category

ATMP Bioprocess Development Services and Manufacturing Platforms

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417)

SIC

Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

AI/ML-Enabled Biologic Discovery Platforms (computational design, in silico screening) (HLAAAIAE)

akta.pro secondary industries

Clinical Trial Material (CTM) Manufacturing & Supply CDMO (HLAGABAK), In Vitro Model Systems & Organoid Platforms (iPSC/organoids, microphysiological systems) (HLAAAIAJ)

Keywords

• ATMP bioprocess development
• Cell therapy manufacturing
• Digital twin bioprocess
• Fixed-bed bioreactor platform
• Gene therapy bioprocessing

Headquarters

HQ city

Leuven

HQ country

Belgium

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Custom Bioprocess Development Services: Antleron provides tailored R&D solutions for ATMP developers, engaging their multidisciplinary team of experts to propose solutions for specific research, development and manufacturing challenges. Services include process development, optimization, and GMP translation support.
2. Technology Platform Licensing: Access to proprietary platforms including CellGuide bioreactor technology and NEXUS digital twin for process development and manufacturing.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

Antleron develops and licenses proprietary bioprocess technology platforms and provides custom R&D services for advanced therapy medicinal product (ATMP) developers. Its core offerings include the CellGuide® scalable fixed-bed bioreactor, the NEXUS digital twin platform, the Cell by Design® cloud-based QbD software, and the BioScout® 4D in vitro screening platform, complemented by smart scaled-down model services, soft sensing, and specific process development for mesenchymal stem cells, rAAV vectors, and extracellular vesicles.

Product overview

Antleron operates as an advanced therapy partner offering a technology platform built around a hybrid R&D approach combining living, digitalized bioprocess ecosystems with computational tools. The core technology stack includes CellGuide (scalable fixed-bed bioreactor platform) paired with NEXUS (digital twin), complemented by soft sensing capabilities and Quality by Design methodology. Their digital twin platform combines hybrid models, computational fluid dynamics, and cost of goods models to accelerate bioprocess development. Service offerings span mesenchymal stem cell bioprocess engineering, rAAV vector manufacturing, and extracellular vesicle production. Supporting software includes Cell by Design (QbD-focused cloud platform) and BioScout (biomaterial screening platform).

Differentiator

Problem solved

Functional benefit

Brands

• CellGuide®: Scalable, closed and automated upstream bioreactor platform for cell and gene therapy manufacturing
• NEXUS
• BioScout®
• Cell by Design®
• LifeFab

Products and services

• CellGuide Scalable, closed, and automated upstream bioreactor platform enabling robust, GMP-aligned production of adherent cell-based therapies such as rAAV vectors and mesenchymal stem cell products.
• NEXUS Digital twin platform integrated with the CellGuide bioreactor that enables in silico bioprocess simulation and optimization using hybrid mechanistic, CFD, and data-driven models for faster, more affordable cell and gene therapy development.
• Digital Twin Platform Proprietary combination of hybrid models, computational fluid dynamics, and cost of goods models deployed in iterative loops with bioreactor experiments for process optimization toward pre-defined objectives in ATMP bioprocessing.
• Smart Scaled-Down Models Service combining custom lab-scale modular bioreactors with the NEXUS-driven digital twin platform to predict, develop, and optimize clinical-scale bioprocesses and manufacturing systems, enabling improved quality, consistency, and scalability from lab to patient for bespoke therapies.
• Soft Sensing Non-invasive monitoring solutions combining in silico models with physical sensors (pH, dissolved oxygen, metabolites, impedance, Raman spectroscopy) to determine critical quality attributes in bioprocesses without destructive sampling.
• Cell by Design Cloud-based software platform co-developed with QbD enabling quality-focused ATMP development through risk-based process assessments and data-driven decisions.
• BioScout Closed, 4D in vitro platform for longitudinal and quality-focused functionality screening of biomaterials and medical devices.
• Mesenchymal Stem Cell (MSC) Bioprocess Services Engineering robust MSC bioprocesses that preserve critical quality attributes from lab to clinic for treating inflammatory, degenerative, and autoimmune conditions.
• rAAV Vector Manufacturing Fixed-bed bioreactor technology tailored for adherent HEK cell culture enabling robust, scalable, and GMP-aligned recombinant adeno-associated viral (rAAV) vector production.
• Extracellular Vesicle Manufacturing Adherent culture in a controlled environment designed to preserve the therapeutic integrity of secreted products from mesenchymal stem cells for next-generation cell-free biologics.

Quantifiable outcome

• Running thousands of multi-parameter simulations only takes a few days, while performing a similar number of complex experiments would take decades
• +1 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature5 records

Partnerships

Eleven partnerships are on record, tiered core and minor.

• AnsyscoreTechnology or Integration · 15 November 2021Antleron joined the Ansys Startup programme and uses Ansys solutions including Fluent for computational fluid dynamics (CFD) simulation. Collaboration enables in silico optimization of cell growth environments and bioreactor design before lab experiments. Joint testimonial presentations at Ansys Simulation World.
• QbD (Quality by Design)coreStrategic or Co-development Partner · 12 August 2021Co-developed Cell by Design platform, a cloud-based software enabling quality-focused ATMP development through risk-based process assessments. QbD provides regulatory expertise and QbD methodology while Antleron contributes ATMP process development expertise.
• NovasigncoreTechnology or Integration · 28 July 2021Collaboration to develop novel digital tools for ATMP bioprocess development. Combines Antleron's ATMP process development and in silico bioprocess simulation expertise with Novasign's hybrid modeling toolbox. Jointly developing next generation modeling solutions using CFD integration and hybrid models.
• LifeLUNGminorStrategic or Co-development PartnerAntleron partners with LifeLUNG Doctoral Network to train next-generation gene therapy professionals. LifeLUNG addresses unmet clinical needs, technology and knowledge gaps through innovation and co-creation. EU Framework Programme for Research and Innovation funded project.
• Ghent UniversitycoreStrategic or Co-development PartnerAcademic collaboration through Baekeland PhD programme. Prof. Thomas De Beer and Prof. Jan Verwaeren serve as academic promotors for Evan's PhD on process analytical technology and modeling of biological systems. Synergy between academic expertise and industrial application.
• RousselotminorStrategic or Co-development PartnerX-Pure by-design collaborative development partnership focused on gelatin-based biomaterials for ATMP applications.
• Tuatara DxminorStrategic or Co-development PartnerPartnership to revolutionize point-of-need diagnostics through personalized care solutions.
• ChemstreamminorStrategic or Co-development PartnerJoint presentation of LifeFab solution at Formnext 2022 for additive manufacturing applications in bioprocessing.
• BioIncubator in LeuvencoreOthersAntleron resides in the BioIncubator in Leuven, providing access to biotech ecosystem and infrastructure.
• EIT HealthminorStrategic or Co-development PartnerAntleron showcased BioScout platform at EIT Health Summit in Paris, highlighting partnership with EIT Health for innovation in health technology.
• GET-IN (GEne Therapy INnovation)minorStrategic or Co-development PartnerTraining network where Antleron hosts DC8 project covered by Katerina Leonida's PhD within the gene therapy innovation program.

Scale indicators2 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Lonza: World's largest CDMO with dedicated cell and gene therapy manufacturing services. Competes with Antleron's CDMO-adjacent services for ATMP process development and GMP manufacturing.
• Cytiva: Global bioprocess equipment and consumables provider (part of Danaher). Broad incumbent offering fixed-bed bioreactors and bioprocess tools overlapping with Antleron's CellGuide platform.
• AGC Biologics: Global CDMO providing cell and gene therapy process development and GMP manufacturing. Overlaps with Antleron's bioprocess development and rAAV vector manufacturing services at the broader incumbent tier.
• Sartorius: Global bioprocess solutions provider offering bioreactors, filtration, and fluid management. Competes with Antleron at the upstream bioreactor layer for ATMP and gene therapy customers.

Direct peers

• Cellares: Well-funded US startup offering automated cell therapy manufacturing platforms (Cell Shuttle). Comparable in targeting ATMP developers with automation/digitalization, but at much larger scale and venture-backed.
• CellGenix: German supplier of GMP-grade raw materials, reagents, and cell therapy manufacturing services. Comparable to Antleron in targeting ATMP developers with enabling tools and process development services.
• RoosterBio: US-based MSC technology company offering bioprocess media, cells, and bioprocess development services. Direct overlap with Antleron's MSC bioprocess engineering and ATMP manufacturing service lines.
• Univercells: Belgian biotech focused on scalable, cost-effective bioprocess and manufacturing solutions for biologics and cell therapies. Comparable mission to Antleron's affordable/equitable ATMP delivery and similar Leuven-area ecosystem.
• ScaleReady (Repligen): Joint venture delivering cell therapy manufacturing platforms, including bioreactor-based and process development solutions. Comparable to Antleron's CellGuide bioreactor + process development offering for cell therapy.

Emerging players

• Kytopen: MIT spin-out offering flow-based, automated cell engineering platforms for cell therapies. Comparable emerging player addressing ATMP manufacturing bottlenecks with novel hardware.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/antleron
• Facebookfacebook.com/Antleron-636057720187424
• LinkedInbe.linkedin.com/company/antleron
• Instagraminstagram.com/antleron.nv/?hl=en

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Antleron